Tempus AI's financials have significantly improved, with positive cash flow expected next quarter. Read why TEM stock is a ...

Jonathan Bluth recently joined BGL as a managing director in the Healthcare & Life Sciences Investment Banking practice, one ...

All on news it just acquired Ambry Genetics, a well-known leader in genetic testing, for $600 million, which included $375 million in cash payments and $225 million in shares. Plus, Nancy Pelosi ...

Adjusted EBITDA for 2025: Expected to be approximately $5 million. Acquisition: Closed the acquisition of Ambry Genetics on February 3. Google Agreement: Extended for another five years.

Linh H. Le is an accomplished finance and accounting executive with extensive knowledge and expertise that he has implemented ...

Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark ...

The market's appetite for AI applications in healthcare is rapidly increasing, with TEM emerging as a top contender in this ...

The Bureau of Labor Statistics reported Wednesday that February prices for food and services haven’t gone up as much as many ...

For the full year, the Data and Services division was a key contributor. The acquisition of Ambry Genetics, finalized in February 2025, further strengthens Tempus’ genomics capabilities by ...